Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

NCT00762684 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped Hepatic safety signal identified.

Conditions

Interventions

Sponsor

Takeda